GILEAD SCIENCES INC 2.95 percent 01Mar2027 is a Corporate bonds world rest issued by Gilead Sciences Inc. on the 15th of September 2016. The bond matures on the 1st of March 2027 and carries the semi-annual coupon of 2.950%. GILEAD (US:375558BM4) is currently rated BBB and has a yield to maturity of 4.284. GILEAD is trading at 96.60 as of the 28th of November 2024, a 0.09% up since the beginning of the trading day. The bond's open price was 96.51. GILEAD has less than a 15 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Ratings for GILEAD SCIENCES INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Our tools can tell you how much better you can do entering a position in GILEAD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Optimization Now
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
GILEAD financial ratios help investors to determine whether GILEAD Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GILEAD with respect to the benefits of owning GILEAD security.